If you missed our latest webinar on the changing landscape of Highly Specialised Technologies in the UK it’s not too late to catch up. View the presentation slides here to see excerpts about overcoming hurdles in the NICE process and our thoughts and considerations on what it takes a Managed Access Agreement (MAA) successful.
One thought on “Optimising Success for Access to Rare Disease Treatments”
This is the perfect webpage for everyone who wishes to understand this topic. You realize so much its almost hard to argue with you (not that I personally would want toÖHaHa). You definitely put a brand new spin on a subject that has been written about for a long time. Great stuff, just great!
Comments are closed.